SZTE Szent-Gyorgyi Albert Klinikai Kozpont ( Site 1010)
Szeged, Csongrad, Hungary
University hospital in Szeged
Szeged, Kálvária sugárút 57., 6725
About SZTE Szent-Gyorgyi Albert Klinikai Kozpont ( Site 1010)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Merck Sharp & Dohme LLC
2
Clinical Trials at SZTE Szent-Gyorgyi Albert Klinikai Kozpont ( Site 1010)
During the past decade, SZTE Szent-Gyorgyi Albert Klinikai Kozpont ( Site 1010) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)
2019-06-13
2025-06-15
Active, not recruiting
907
Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Participants Who Are Cisplatin-ineligible or Decline Cisplatin With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)
2019-07-24
2027-12-15
Recruiting
857
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "SZTE Szent-Gyorgyi Albert Klinikai Kozpont ( Site 1010)"
#1 collaborator was "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator and "Seagen Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at SZTE Szent-Gyorgyi Albert Klinikai Kozpont ( Site 1010)
According to Clinical.Site data, the most researched conditions in "SZTE Szent-Gyorgyi Albert Klinikai Kozpont ( Site 1010)" are
"Urinary Bladder Cancer, Muscle-invasive" (2 trials). Many other conditions were trialed in "SZTE Szent-Gyorgyi Albert Klinikai Kozpont ( Site 1010)" in a lesser frequency.
Clinical Trials Intervention Types at SZTE Szent-Gyorgyi Albert Klinikai Kozpont ( Site 1010)
Most popular intervention types in "SZTE Szent-Gyorgyi Albert Klinikai Kozpont ( Site 1010)" are "Drug" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Pembrolizumab" (2 trials), "Surgery (radical cystectomy (RC) plus Pelvic Lymph Node Dissection [PLND])" (2 trials), "Cisplatin" (1 trials), "Enfortumab Vedotin" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at SZTE Szent-Gyorgyi Albert Klinikai Kozpont ( Site 1010)
The vast majority of trials in "SZTE Szent-Gyorgyi Albert Klinikai Kozpont ( Site 1010)" are
2 trials for "All" genders.
Clinical Trials Status at SZTE Szent-Gyorgyi Albert Klinikai Kozpont ( Site 1010)
Currently, there are NaN active trials in "SZTE Szent-Gyorgyi Albert Klinikai Kozpont ( Site 1010)".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in SZTE Szent-Gyorgyi Albert Klinikai Kozpont ( Site 1010),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in SZTE Szent-Gyorgyi Albert Klinikai Kozpont ( Site 1010), 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".